Intellijoint Surgical launches new surgical planning software: Intellijoint VIEW™
October 21, 2021 10:30 ET
|
Intellijoint Surgical
Canada, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Kitchener, ON – October 21, 2021 – Intellijoint Surgical is excited to announce a new preoperative surgical planning product for total hip arthroplasty....
MedCAD Launches AccuPlate® Patient-Specific Plates after 510(k) Market Clearance
September 15, 2021 08:00 ET
|
MedCAD
DALLAS, Sept. 15, 2021 (GLOBE NEWSWIRE) -- After months of developmental groundwork, MedCAD is proud to officially announce FDA 510(k) market clearance for AccuPlate® Patient-Specific Plates for...
Globus Medical Announces FDA 510(k) Clearance for Excelsius3D™
August 16, 2021 16:30 ET
|
Globus Medical
AUDUBON, Pa., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that Excelsius3D™, an intelligent intraoperative...
Globus Medical Reports Second Quarter 2021 Results
August 04, 2021 16:15 ET
|
Globus Medical
AUDUBON, Pa., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30,...
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
July 16, 2021 08:30 ET
|
Globus Medical
AUDUBON, Pa., July 16, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June...
Globus Medical Announces Completion of 20,000 Procedures Utilizing ExcelsiusGPS®
July 15, 2021 16:30 ET
|
Globus Medical
AUDUBON, Pa., July 15, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that over 20,000 spine procedures have been performed...
MedCAD Receives 510(k) Market Clearance for New AccuPlan® System
November 10, 2020 07:00 ET
|
MedCAD
DALLAS, Nov. 10, 2020 (GLOBE NEWSWIRE) -- MedCAD is proud to announce 510(k) market clearance for its new AccuPlan® System through the Food and Drug Administration (FDA). The AccuPlan® System...
Globus Medical Schedules Second Quarter 2020 Earnings Release and Conference Call
July 21, 2020 16:15 ET
|
Globus Medical
AUDUBON, Pa., July 21, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended June...
Globus Medical Schedules First Quarter 2020 Earnings Release and Conference Call
April 16, 2020 16:30 ET
|
Globus Medical
AUDUBON, Pa., April 16, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March...
Globus Medical Reports Fourth Quarter and Full Year 2019 Results
February 20, 2020 16:15 ET
|
Globus Medical
AUDUBON, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year...